{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:11:34Z","timestamp":1789931494411,"version":"4.0.1"},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,1,16]],"date-time":"2004-01-16T00:00:00Z","timestamp":1074211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2004,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Argininosuccinate synthetase (ASS) was the first of two enzymes to convert citrulline to arginine. This pathway allowed cells to synthesize arginine from citrulline, making this amino acid nonessential for the growth of most mammalian cells. Previous studies demonstrated that several human tumor cell lines were auxotrophic for arginine due to an inability to express ASS. Selective elimination of arginine from the circulation of animals with these tumors is a potentially effective anticancer treatment. The purpose of these experiments was to determine the frequency of ASS deficiency and arginine auxotrophy in a variety of human malignant tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The authors analyzed the expression of ASS by immunohistochemistry with a monoclonal antibody in a variety of human tumor biopsies. They found that the incidence of ASS deficiency varied greatly with the tumor type and tissue of origin.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Melanoma, hepatocellular carcinoma, and prostate carcinoma were most frequently deficient in ASS. Some human cancers were almost always positive for ASS (e.g., lung and colon carcinomas). However, other human cancers, including sarcomas, invasive breast carcinoma, and renal cell carcinoma, also were sometimes ASS deficient.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>These data indicated that immunohistochemical detection of ASS may prove an effective means for determining ASS deficiency in malignant human tumors and for identifying patients most likely to respond to arginine deprivation therapy. Based on these results, human clinical trials using arginine\u2010degrading enzyme therapy to treat patients with advanced melanoma or hepatocellular carcinoma have been initiated. Cancer 2004;100:826\u201333. \u00a9 2004 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.20057","type":"journal-article","created":{"date-parts":[[2004,2,5]],"date-time":"2004-02-05T05:00:32Z","timestamp":1075957232000},"page":"826-833","source":"Crossref","is-referenced-by-count":258,"title":["Incidence and distribution of argininosuccinate synthetase deficiency in human cancers"],"prefix":"10.1002","volume":"100","author":[{"given":"Brian J.","family":"Dillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor G.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Curley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Mark","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Holtsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Bomalaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,2,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60222-7"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4811-9_69"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(98)00015-8"},{"key":"e_1_2_6_5_2","unstructured":"RogersQR.Species variation in arginine requirements. Proceedings from a symposium honoring Willard J. Visek\u2014from ammonia to cancer and gene expression. Special Publication 86 Agriculture Experiment Station University of Illinois April 4\u20135 1994:9\u201321."},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/0148607186010002227"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(60)90225-1"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/112.1.7"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","unstructured":"KraemerPM DefendiV HayflickL MansonLAl.Mycoplasma (PPLO) strains with lytic activity for murine lymphoma cells in vitro.Proc Soc Exp Biol Med.1963;112:381\u2013387.","DOI":"10.3181\/00379727-112-28052"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-115-28871"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/S0021-9258(18)96610-X","article-title":"The generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07","volume":"241","author":"Schimke RT","year":"1964","journal-title":"J Biol Chem"},{"key":"e_1_2_6_12_2","first-page":"345","article-title":"Tumor growth inhibitory activity of a lymphocyte blastogenesis inhibitory factor","volume":"50","author":"Sugimura K","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_6_13_2","first-page":"5443","article-title":"Pegylated arginine deiminase (ADI\u2010SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo","volume":"62","author":"Ensor CM","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199209000-00007"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000474998","article-title":"Characterization of human wild type and mutant argininosuccinate synthase proteins expressed in bacterial cells","volume":"48","author":"Kobayashi SN","year":"1994","journal-title":"Enz Protein"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj0240589"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1991.01410350066010"},{"key":"e_1_2_6_18_2","first-page":"2932","article-title":"Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two\u2010stage epidermal carcinogenesis in the mouse","volume":"51","author":"Gonzalez GG","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1163"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.4.1819"},{"key":"e_1_2_6_21_2","first-page":"4522","article-title":"Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma\u2010infected cell line","volume":"50","author":"Miyazaki K","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910510213"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1993.tb02821.x"},{"key":"e_1_2_6_24_2","first-page":"2647","article-title":"Static and dynamic aspects of amino acid pools in rat liver and Morris hepatomas 9618A and 7800","volume":"334","author":"Moyer GH","year":"1974","journal-title":"Cancer Res"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1353"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1995.tb03094.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(02)00042-1"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj3630581","article-title":"Enzymatic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor \u03b1 and endotoxin","volume":"363","author":"Thomas JB","year":"2002","journal-title":"Biochem J"},{"key":"e_1_2_6_29_2","first-page":"248","article-title":"Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production","volume":"8","author":"Dillon BJ","year":"2002","journal-title":"Med Sci Monit"},{"key":"e_1_2_6_30_2","first-page":"591","article-title":"Pharmacogenetic application in drug development and clinical trials","volume":"29","author":"Shi MM","year":"2001","journal-title":"Drug Met Disp"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1139\/m70-071"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1004"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401763"},{"key":"e_1_2_6_34_2","unstructured":"JonesJB.The effect of arginine deiminase on murine leukemia lymphoblasts[Ph.D. dissertation]. Oklahoma City OK: University of Oklahoma 1981:1\u2013169."},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1656(94)90050-7"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02619581"},{"key":"e_1_2_6_37_2","first-page":"2680","article-title":"Reduction in cellular tumorigenicity after Mcyoplasmad infection and elimination of Mcyoplasmad from infected cultures by passage in nude mice","volume":"37","author":"van Diggelen OP","year":"1977","journal-title":"Cancer Res"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.20057","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.20057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:14:21Z","timestamp":1760264061000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.20057"}},"subtitle":["A method for identifying cancers sensitive to arginine deprivation"],"short-title":[],"issued":{"date-parts":[[2004,2,3]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,2,15]]}},"alternative-id":["10.1002\/cncr.20057"],"URL":"https:\/\/doi.org\/10.1002\/cncr.20057","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,3]]}}}